Post-diagnosis aspirin use and survival in veterans with head and neck cancer. (Record no. 6222)

000 -LEADER
fixed length control field 02580nam a22004937a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 190108s20182018 xxu||||| |||| 00| 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
Classification number 30537085
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1043-3074
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/hed.25518 [doi]
190 ## -
-- Lumley CJ
190 ## -
-- Kaffenberger TM
190 ## -
-- Desale S
190 ## -
-- Tefera E
190 ## -
-- Han CJ
190 ## -
-- Rafei H
190 ## -
-- Maxwell JH
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Lumley, Catherine J
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Desale, Sameer
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Tefera, Eshetu
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Maxwell, Jessica H
245 ## - TITLE STATEMENT
Title Post-diagnosis aspirin use and survival in veterans with head and neck cancer.
251 ## -
-- Head & Neck. 2018 Dec 11
252 ## -
-- Head Neck. 2018 Dec 11
253 ## -
-- Head & neck
260 ## - PUBLICATION, DISTRIBUTION, ETC.
-- aheadofprint
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Date of publication, distribution, etc. 2018
269 ## -
-- FY2019
501 ## - WITH NOTE
With note Available online from MWHC library: 1996 - present
520 ## - SUMMARY, ETC.
Summary, etc. BACKGROUND: Our objective was to determine the effect of post-diagnosis aspirin use on survival in veterans with head and neck squamous cell carcinoma.
520 ## - SUMMARY, ETC.
Summary, etc. METHODS: Retrospective cohort study of 584 veterans with head and neck squamous cell carcinoma treated at the Washington DC VA Medical Center between 1995 and 2015. Charts were queried for clinical-pathologic data, aspirin prescriptions, and outcome. The Kaplan-Meier method was used to determine overall survival (OS) and disease-specific survival (DSS) among aspirin users and nonusers.
520 ## - SUMMARY, ETC.
Summary, etc. RESULTS: A total of 329 patients met inclusion criteria. Primary subsites included oropharynx (n = 143), larynx (n = 105), oral cavity (n = 62), and hypopharynx (n = 19). Eighty-four patients were aspirin users (25.5%). Aspirin users demonstrated significantly better 3-year OS and DSS (78.6% and 88.1%) compared to nonaspirin users (OS: 55.9% and DSS: 70.2%; P = .0003 and P = .0019, respectively). On multivariate analysis, aspirin use remained independently associated with improved survival.
520 ## - SUMMARY, ETC.
Summary, etc. CONCLUSION: Aspirin use following diagnosis and curative treatment of head and neck squamous cell carcinoma is associated with improved OS and DSS.
520 ## - SUMMARY, ETC.
Summary, etc. Copyright (c) 2018 Wiley Periodicals, Inc.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element IN PROCESS -- NOT YET INDEXED
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Geographic name MedStar Health Research Institute
656 ## - INDEX TERM--OCCUPATION
Occupation Otolaryngology
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Geographic name MedStar Washington Hospital Center
657 ## - INDEX TERM--FUNCTION
Function Journal Article
858 ## -
-- Lumley, Catherine J
-- https://orcid.org/0000-0001-8609-9002
857 ## -
-- https://dx.doi.org/10.1002/hed.25518
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection code Permanent Location Current Location Date acquired Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 2019-01-08 30537085 2019-01-08 2019-01-08 Journal Article

Powered by Koha